1. Home
  2. NVEI vs OGN Comparison

NVEI vs OGN Comparison

Compare NVEI & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVEI
  • OGN
  • Stock Information
  • Founded
  • NVEI 2003
  • OGN 1923
  • Country
  • NVEI Canada
  • OGN United States
  • Employees
  • NVEI N/A
  • OGN N/A
  • Industry
  • NVEI
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVEI
  • OGN Health Care
  • Exchange
  • NVEI Nasdaq
  • OGN Nasdaq
  • Market Cap
  • NVEI 4.7B
  • OGN 4.7B
  • IPO Year
  • NVEI 2021
  • OGN N/A
  • Fundamental
  • Price
  • NVEI $33.99
  • OGN $15.03
  • Analyst Decision
  • NVEI Hold
  • OGN Hold
  • Analyst Count
  • NVEI 14
  • OGN 3
  • Target Price
  • NVEI $32.38
  • OGN $21.33
  • AVG Volume (30 Days)
  • NVEI 1.1M
  • OGN 3.0M
  • Earning Date
  • NVEI 11-12-2024
  • OGN 10-31-2024
  • Dividend Yield
  • NVEI 1.18%
  • OGN 7.45%
  • EPS Growth
  • NVEI N/A
  • OGN 120.97
  • EPS
  • NVEI 0.16
  • OGN 5.04
  • Revenue
  • NVEI $1,359,722,000.00
  • OGN $6,409,000,000.00
  • Revenue This Year
  • NVEI $18.83
  • OGN $3.13
  • Revenue Next Year
  • NVEI $15.63
  • OGN $2.18
  • P/E Ratio
  • NVEI $203.07
  • OGN $2.98
  • Revenue Growth
  • NVEI 24.89
  • OGN 4.21
  • 52 Week Low
  • NVEI $19.07
  • OGN $10.84
  • 52 Week High
  • NVEI $34.00
  • OGN $23.10
  • Technical
  • Relative Strength Index (RSI)
  • NVEI 72.51
  • OGN 25.51
  • Support Level
  • NVEI $33.42
  • OGN $15.25
  • Resistance Level
  • NVEI $33.70
  • OGN $15.85
  • Average True Range (ATR)
  • NVEI 0.13
  • OGN 0.68
  • MACD
  • NVEI 0.04
  • OGN -0.13
  • Stochastic Oscillator
  • NVEI 98.49
  • OGN 4.06

About NVEI Nuvei Corporation Subordinate Voting Shares

Nuvei Corp is a provider of payment technology solutions to merchants and partners. The solutions provided are mobile payments, online payments, and In-store payments. Its geographical segments are North America; Europe, the Middle East, and Africa; Latin America; and the Asia Pacific. The vast majority of the company's revenue is generated from North America and EMEA.

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: